UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
May 27, 2016
Date of Report (Date of earliest event reported)
PhotoMedex, Inc.
(Exact name of registrant as specified in its charter)
Nevada | 0-11635 | 59-2058100 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Ident. No.) | ||
100 Lakeside Drive, Suite 100, Horsham, Pennsylvania | 19044 | |||
(Address of principal executive offices) | (Zip Code) | |||
(610) 208-1991 Registrant’s telephone number, including area code | ||||
N/A | ||||
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
Item 1.02 Termination of a Material Definitive Agreement.
On May 27, 2016, PhotoMedex, Inc. (“PHMD”), Radiancy, Inc., an indirectly wholly-owned subsidiary of PHMD (“Radiancy”), and Photomedex Technology, Inc., a wholly-owned subsidiary of PHMD (“P-Tech”), terminated: (a) the Agreement and Plan of Merger and Reorganization, dated as of February 19, 2016 (the “Radiancy Merger Agreement”), among PHMD, Radiancy, DS Healthcare Group, Inc. (“DSKX”) and PHMD Consumer Acquisition Corp., a wholly-owned subsidiary of DSKX (“Merger Sub A”), and (b) the Agreement and Plan of Merger and Reorganization, dated as of February 19, 2016 (the “P-Tech Merger Agreement” and together with the Radiancy Merger Agreement, the “Merger Agreements”), among PHMD, P-Tech, DSKX, and PHMD Professional Acquisition Corp., a wholly-owned subsidiary of DSKX (“Merger Sub B”). Pursuant to the Merger Agreements, Radiancy was to merge with Merger Sub A, with Radiancy as the surviving corporation in such merger, P-Tech was to merge with Merger Sub B, with P-Tech as the surviving corporation in such merger, and DSKX was to become the holding company for Radiancy and P-Tech.
Given the material breaches identified in PHMD’s notice to DSKX, and filed as Exhibit 99.1 to PHMD’s Current Report on Form 8-K filed on April 12, 2016, and other disclosures and communications by DSKX, in connection with PHMD’s termination of the Merger Agreements and pursuant to their terms, PHMD is seeking to recover a termination fee of $3.0 million, an expense reimbursement of up to $750,000 and its liabilities and damages suffered as a result of DSKX’s failures and breaches in connection with each of the Merger Agreements. On May 27, 2016, PHMD, Radiancy and P-Tech filed a complaint in the U.S. District Court for the Southern District of New York alleging breaches of the Merger Agreements by DSKX and seeking the damages described in the foregoing sentence.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PHOTOMEDEX, INC. | ||||
Dated: May 31, 2016 | ||||
By: | /s/ Dolev Rafaeli | |||
Dolev Rafaeli | ||||
Chief Executive Officer | ||||